Acute lymphoblastic leukemia (ALL) is the most common malignancy in childhood,
accounting for almost 30% of pediatric cancers. Despite the high rate of cure, ALL is one of …

Background Several studies of pediatric acute myeloid leukemia have described the various
type-I or type-II aberrations and their relationship with clinical outcome. However, there has …

Abstract Purpose of the Review Infant leukemia is a rare, distinct subgroup of pediatric acute
leukemias diagnosed in children under 1 year of age and characterized by unique …

Acute Iymphoblastic leukemia (ALL), previously reviewed in this journal 5 years
ago,'remains the most common cancer and the second leading cause of death in children …

Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. In the past
ALL was intractable but now the survival probability is as high as 80–90%. Improved …

From 1981 to 2000, a total of 1823 children with acute myeloid leukemia (AML) enrolled on
four consecutive Pediatric Oncology Group (POG) clinical trials. POG 8101 demonstrated …

The clinical outcome of acute myeloid leukaemia (AML) in children has improved
considerably using intensive chemotherapy and/or stem cell transplantation. This leads to …

Clinical and laboratory features at presentation were correlated with morphological (FAB)
subclass of AML in a group of 112 children diagnosed between 1972 and 1982. Patients …

Objective: Leukemia is the most common pediatric malignancy and a major cause of
morbidity and mortality in children. Among all subtypes, a lack of consensus exists regarding …

Recent advances in the genetic understanding of acute myeloid leukemia (AML) have
improved clinical outcomes in pediatric patients. However,∼ 40% of patients with pediatric …